Tumor-associated antigens (TAAs) expressed on the surface of tumor cells are processed into short peptide fragments and presented to the cell surface via MHC class I molecules.CD8+ T cells specifically recognize the MHC I-antigenic peptide complexes via the TCR, while the CD8 co-receptor enhances the binding stability. This evidence concerns the gene CD8A and neoplasm.